Podcasts about Maoz

In today's podcast I speak with Israeli and Palestinian peace activists, Maoz Inon and Aziz Abu Sarah.Maoz is an Israeli whose parents were killed by Hamas on Oct 7.Aziz is a Palestinian whose brother was killed by Israeli soldiers.These two men work together to spread and create a message of peace and understanding so, hopefully, one day soon we can bring an end to this conflict.Get 10% off at Marek Health ► https://marekhealth.com/syattHow to Be a Personal Trainer Podcast ► https://bit.ly/48kp3GUAziz's IG ► https://www.instagram.com/azizabusarah/Maoz's IG ► https://www.instagram.com/maozinon/Buy Their Book "The Future is Peace" ► https://amzn.to/4tC6je5InterAct International ► https://www.instagram.com/interact.international.dnec?igsh=MTkyZ2R4a2hvZ3ZidQ==

Aziz Abu Sarah, a Palestinian whose brother was killed by the IDF, and Maoz Inon, an Israeli whose parents were killed by Hamas on October 7, 2023, talked about their friendship and efforts to figand I Historic Synagogue in Washington, D.C. Learn more about your ad choices. Visit megaphone.fm/adchoices

Aziz Abu Sarah, a Palestinian whose brother was killed by the IDF, and Maoz Inon, an Israeli whose parents were killed by Hamas on October 7, 2023, talked about their friendship and efforts to figand I Historic Synagogue in Washington, D.C. Learn more about your ad choices. Visit megaphone.fm/adchoices

‘We are transforming feelings of revenge into reconciliation. We are transforming despair into hope, trauma into healing. So the future is peace is also like a manual, like a guide, not just for a shared journey across the holy land, but a guide for human conscience.'Rajan Datar speaks to Palestinian and Israeli authors and peace activists Aziz Abu Sarah and Maoz Inon.Maoz Inon‘s parents were killed during the Hamas attacks of October 7th. Aziz Abu Sarah's brother died after being detained for nearly a year in an Israeli military prison. Together, they have forged an unlikely friendship across the Israeli Palestine divide, become leading voices for reconciliation, arguing that peace can only be built through empathy, dialogue and a recognition of each other's humanity.Their new book, The Future Is Peace, chronicles their eight day drive across Israel and Palestine. They talk about loss, forgiveness, and why they remain hopeful despite the devastation of war. The Interview brings you conversations with people shaping our world, from all over the world. You can listen on the BBC World Service on Mondays, Wednesdays and Fridays at 0800 GMT. Or you can listen to The Interview as a podcast, out three times a week on BBC Sounds or wherever you get your podcasts. Presenter: Rajan Datar Producer: Farhana Haider Editor: Justine LangGet in touch with us on email TheInterview@bbc.co.uk and use the hashtag #TheInterviewBBC on social media.(Image: Aziz Abu Sarah and Maoz Inon. Credit: Getty)

Palestinian Aziz Abu Sarah lost his brother to Israeli authorities in the second Intifada. Israeli Jew Maoz Inon lost both his parents to Hamas on October 7th. In their book,The Future Is Peace, these two travel guides to Israel/Palestine and lifelong peace activists, take readers on a journey across their holy bloodstained land. They share the mythic, political, and personal history that divides but also binds them and their peoples. This episode, recorded in front of an audience at a LiveTalksLA event in April, punctuated often by laughter, makes clear their love for each other and the land they share as well as their absolute conviction that dialogue and peace must and will prevail. You can learn more at thefutureispeace.com

durée : 00:23:48 - Les interviews d'Inter - par : Ali Baddou, Marion L'Hour - Aziz Abu Sarah, militant palestinien pour la paix, formateur dans la résolution des conflits, et Maoz Inon, militant israélien pour la paix, ont cofondé InterAct International. Ils ont coécrit "La paix est notre avenir. Un voyage de réconciliation en Terre sainte (L'arbre qui marche). Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

durée : 03:00:17 - Le 6/9 - par : Ali Baddou, Marion L'Hour - Les invités du 6/9 à 7h50 Raphaël Garrigos, directeur de la rédaction et cofondateur des Jours et à 8h20 Aziz Abu Sarah, militant palestinien pour la paix et Maoz Inon, auteurs de “La paix est notre avenir. Un voyage de réconciliation en Terre Sainte” aux éditions L'arbre qui marche. - réalisation : Capucine Aubert, Amélie Stadelmann, Mathilde Khlat, Perrine Malinge, Joachim Taieb Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

A Palestinian and Israeli who have both lost family members in the conflict in the Middle East spoke to Perspective about their message of hope for the world. Aziz Abu Sarah is a Palestinian whose brother was killed by the Israeli military, and Maoz Inon an Israeli whose parents were killed by Hamas in October of 2023.  It was after their deaths, that Aziz reached out to Maoz, and from that moment grew their book “The future of Peace: A Shared Journey Across the Holy Land”, which is also now being launched in French as “La Paix est notre Avenir”.

Aziz Abu Sarah et Maoz Inon pour leur livre « La paix est notre avenir » publié aux éditions de l'arbre qui marche. À propos du livre : « La paix est notre avenir » paru aux éditions l'arbre qui marche " Notre peuple ne se divise pas entre Israéliens et Palestiniens, mais entre ceux qui croient à la paix, et ceux qui n'y croient pas, ou pas encore " Aziz et Maoz ne devraient pas être amis. Le frère d'Aziz a été tué par des militaires israéliens. Les parents de Maoz ont été tués par le Hamas le 7 octobre 2023. Aujourd'hui, ils nous invitent à un voyage de huit jours à travers la Terre sainte, à la découverte de l'histoire mythique, politique et intime qui relie Palestiniens et Israéliens autant qu'elle les divise. A Jérusalem, à Nazareth, en Cisjordanie, sur les hauteurs de Gaza, nous découvrons deux peuples en train de perdre espoir, mais aussi une nouvelle réalité occultée par l'actualité : des milliers de Palestiniens et d'Israéliens veulent vivre ensemble, comme leurs ancêtres l'ont fait pendant des siècles avant eux. Au fur et à mesure de notre voyage, nous découvrons non seulement qu'une réconciliation est possible, mais qu'elle est inévitable. " Un livre qui nous brise le cœur, et qui nous répare. " Colum McCann, prix du meilleur livre étranger pour Apeirogon " Le livre dont nous avions besoin "Michael Morpurgo, auteur de Cheval de Guerre

In this episode, I sit down with Maoz Tal, CEO & Founder of But Better Snacks, to talk about what it really takes to build a health-focused food brand in today's market. Alongside his brother Roy Tal, co-founder and COO, Maoz has been building But Better Snacks with one goal in mind — creating snack options that are actually better for you without sacrificing taste.We get into the reality of competing in the health food industry, how consumer habits are changing, the challenges of scaling a physical product business, branding, distribution, and what most “healthy” snack brands are getting wrong. Maoz also shares lessons from building the company from the ground up and the mindset required to survive in a brutally competitive market.If you're interested in entrepreneurship, e-commerce, consumer brands, health products, or building a business from scratch, this episode is packed with insights.Make sure to like, comment, and subscribe if you enjoyed the conversation.----⏱️ TIMESTAMPS / CHAPTERS

Maoz Inon lost his parents on October 7th. They were in their safe room, 200 meters from the Gaza border wall, when Hamas came. Aziz Abu Sarah lost his brother — the person who raised him — after he was tortured in an Israeli prison during the First Intifada. Two days after October 7th, Aziz wrote Maoz a letter. Maoz wrote back. That exchange became a friendship, a journey across the Holy Land, and now a New York Times bestselling book: "The Future Is Peace." This is not a polemic. It is not a policy paper. It is an invitation — to sit with grief that belongs to both sides, to doubt the narratives handed to you, and to imagine that the conflict will end. Because, as Maoz says, it will. The only question is when and how many more lives are lost before it does. Yonit and Jonathan talk with them about Hamas, religious extremism, on what peace would actually look like, on whether Israelis have any reason to trust again.    Watch on Youtube: https://youtu.be/0nJ3q4kvVPs ⏱ CHAPTERS: [00:00] Intro — who are Aziz and Maoz? [00:47] Maoz: the last phone call with his parents on October 7th [02:57] Aziz: losing a brother who was his parent [04:34] The kind of people Maoz's parents were [08:12] Aziz reaches out — what the letter said [09:47] Why Aziz wanted to learn Hebrew [14:23] Are they the minority? How do you make peace mainstream? [16:36] What would peace actually look like? [20:18] Yonit pushes: what about Hamas, what about religion? [24:44] The travelogue — hospitals, holy sites, and shared grief [26:38] Do Israelis and Palestinians have to give up their narratives? [33:27] What do Aziz and Maoz still disagree on? [38:48] Closing — the book, the journey, the invitation

Palestinian Aziz Abu Sarah and Israeli Maoz Inon forged a bond when the world expected them to be enemies. Aziz, a Palestinian, lost his brother after he was arrested and tortured by the IDF. Maoz, an Israeli, lost both of his parents to Hamas militants on October 7. In the wake of tragedy, the lifelong peace activists chose to fight for peace because everything other than peace has failed. In The Future Is Peace, Sarah and Inon walk the physical and emotional landscapes of their intertwined histories – from the ruins of Gaza's border communities to Jerusalem's winding stone alleyways, from the hills of Galilee to Bethlehem's concrete separation barrier. In conversation with Sixth & I's Senior Rabbi, Aaron Potek. This program was held on April 16, 2026. Thanks to our promotional partner, New Jewish Narrative. Watch on YouTube.

This Yom HaZikaron, we sit with two fathers who lost their sons in the early months of the war. Eitan Morell shares the story of his son Maoz — a kid with ADHD and learning difficulties who walked into a yeshiva that didn't want him, refused to leave, and became the kind of soldier his unit looked up to. Eitan reflects on what it means to suddenly see your child's whole life in reverse — and how grief reveals a person you thought you already knew.Rob Airley shares the story of his son Binyamin — named best soldier in his platoon, loved by commanders and chaverim alike. The kind of guy who, moments before being killed, volunteered to run into a building because his unit needed him. Rob talks about learning to grieve without falling apart — and what it looks like to keep laughing and dancing in the house when Binyamin is no longer at the table.We end off with exerpts from 3 other episodes, about the beauty of living in Israel. Shtark Tank episodes with Eli Freedman and Yaakov Ehrenkranz, and Yaakov's appearance on the DHR podcast hosted by Zak Lenik.Make sure to sign up for newsletter at ShtarkTank.orgTo support Beit Binyamin click hereTo watch the movie about Maoz Morell click hereChapters:00:00:00 Intro00:04:20 Eitan Morell remembers his son Maoz00:39:34 Rob Airley remembers his son Binyamin01:11:25 Shtark Tank with Eli Freedman0:1:23:17 Shtark Tank with Yaakov Ehrenkranz01:33:24 Yaakov on DHR Podcast

Brian Greenaway, director of Maoz, speaks on how reaching Israel with the gospel has been the focus of Maoz for 50 years, supporting individual believers, planting congregations, and serving communities from red light districts to rehabilitation centers, bringing together Jewish and Arab believers through the transformative power of the Gospel.All Nations Christian Centre is an Elim Pentecostal Church in Reading, UK.For more information, please visit our website: https://www.allnationselim.orgOr follow us on Facebook and Instagram @allnationselim

This episode features the audio from a NJN webinar, originally recorded on February 4th, 2026, hosted by Hadar Susskind. Maoz Inon's parents were killed by Hamas on October 7. Aziz Abu Sarah's brother died shortly after being beaten in an Israeli prison. But these two individuals did not turn their pain into a desire for retribution. Instead, they draw on their personal tragedies to fuel peace activism. Their partnership is a challenge to the idea that Israelis and Palestinians are destined to be adversaries. At a moment when public conversations about Israel and Palestine feel more polarized than ever, New Jewish Narrative is bringing together two voices who refuse to give up on our shared humanity. Preorder Aziz and Maoz's upcoming book at thefutureispeace.com. Check out their peacebuilding work at iinteract.org.

Rabbi Breitowitz- Chanukah; Maoz Tzur by Mayanot

Paul Liberman became a believer in the Messiah in 1971. He was instrumental in founding two Messianic Congregations: Beth Messiah Messianic Congregation in Washington, D.C.and Tree of Life in San Diego, CA.He also served as a congregational leader at Beit Asaph in Netanya, Israel, when he resided in the Land for nine years. There, he was the Executive Director of The Joseph Project, Ltd.(humanitarian aid importer), and was elected Chairman of the Messianic Political Action Committee.For five years, he served as the Executive Director of the International Messianic Alliance, was the publisher of “The Messianic Times” newspaper for six years, a founding board member of MAOZ, Inc. (Israel), former Executive Director of the Alliance for Israel Advocacy, and past President of the Messianic Jewish Alliance of America (MJAA).In September of 2023, He received a Lifetime Achievement award from the MJAA, and was recently elected President of the International Messianic Jewish Alliance, at their annualmeeting in October. His greatest achievements are still unchanged, the husband to one, the father of two and the leader of many, at Ohav Shalom Messianic Congregation, in Cathedral City, California.

WOW!!!

JCO PO author Dr. Asaf Maoz at Dana-Farber Cancer Institute shares insights into article, “Causes of Death Among Individuals with Lynch Syndrome in the Immunotherapy Era.” Host Dr. Rafeh Naqash and Dr. Maoz discuss the causes of death in individuals with LS and the evolving role of immunotherapy. TRANSCRIPT Dr. Rafeh Naqash: Hello, and welcome to JCO Precision Oncology Conversations, where we bring you engaging conversations with authors of clinically relevant and highly significant JCOPO articles. I'm your host, Dr. Rafeh Naqash, podcast editor for JCO Precision Oncology and Associate Professor Medicine, at the OU Health Stephenson Cancer Center. Today, I'm super thrilled to be joined by Dr. Asaf Maoz, Medical Oncologist at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and faculty at the Harvard Medical School, and also lead author on the JCO Precision Oncology article entitled "Causes of Death Among Individuals with Lynch Syndrome in the Immunotherapy Era." This publication will be a concurrent publication with an oral presentation at the annual CGA meeting. At the time of this recording, our guest's disclosures will be linked in the transcript. Asaf, I'm excited to welcome you on this podcast. Thank you for joining us today. Dr. Asaf Maoz: Thank you so much for highlighting our paper. Dr. Rafeh Naqash: Absolutely. And I was just talking to you that we met several years back when you were a trainee, and it looks like you've worked a lot in this field now, and it's very exciting to see that you consider JCOPO as a relevant home for some of your work. And the topic that you have published on is of significant interest to trainees from a precision medicine standpoint, to oncologists in general, covers a lot of aspects of immunotherapy. So, I'm really excited to talk to you about all of this. Dr. Asaf Maoz: Me too, me too. And yeah, I think JCOPO has great content in the area of cancer genetics and has done a lot to disseminate the knowledge in that area. Dr. Rafeh Naqash: Wonderful. So, let's get started and start off, given that we have hosts of different kinds of individuals who listen to this podcast, especially when driving from home to work or back, for the sake of making everything simple, can we start by asking you what is Lynch syndrome? How is it diagnosed? What are some of the main things to consider when you're trying to talk an individual where you suspect Lynch syndrome? Dr. Asaf Maoz: Lynch syndrome is an inherited predisposition to cancer, and it is common. So, we used to think that, or there's a general notion in the medical community that it is a rare condition, but we actually know now from multiple studies, including studies that look at the general population and do genetic testing regardless of any clinical phenotype, that Lynch syndrome is found in about 1 in 300 people in the general population. If you think about it in the United States, that means that there are over a million people living with Lynch syndrome in the United States. Unfortunately, most individuals with Lynch syndrome don't know they have Lynch syndrome at the current time, and that's where a lot of the efforts in the community are being made to help detect more individuals who have Lynch syndrome. Lynch syndrome is caused by pathogenic germline variants in mismatch repair genes, MLH1, MSH2, MSH6, or PMS2, or as a result of pathogenic variants in EPCAM that cause silencing of the MSH2 gene. Dr. Rafeh Naqash: Excellent. Thank you for that explanation. Now, one of the other things I also realized, similar to BRCA germline mutations, where you require a second hit for individuals with Lynch syndrome to have mismatch repair deficient cancers, you also require a second hit to have that second hit result in an MSI-high cancer. Could you help us understand the difference of these two concepts where generally Lynch syndrome is thought of to be cancers that are mismatch repair deficient, but that's not necessarily true for all cases as we see in your paper. Can you tease this out for us a little bit more? Dr. Asaf Maoz: Of course, of course. So, the germline defect is in one of the mismatch repair genes, and these genes are responsible for DNA mismatch repair, as their name implies. Now, in a normal cell, we think that one working copy is generally enough to maintain the mismatch repair machinery intact. What happens in tumors, as you alluded to, is that there is a second hit in the same mismatch repair gene that has the pathogenic germline variant, and that causes the mismatch repair machinery not to work anymore. And so what happens is that there is formation of mutations in the cancer cell that are not present in other cells in the body. And we know that there are specific types of mutations that are associated with defects in mismatch repair mechanisms, and those are associated a lot of times with frameshift mutations. And we have termed them ‘microsatellites'. So there are areas in the genome that have repeats, for example, you know, if you have AAAA or GAGA, and those areas are particularly susceptible to mutations when the mismatch repair machinery is not working. And so we can measure that with DNA microsatellite instability testing. But we can also get a sense of whether the mismatch repair machinery is functioning by looking at protein expression on the surface of cancer cells and by doing immunohistochemistry. More recently, we're also able to infer whether the mismatch repair machinery is working by doing next-generation sequencing and looking at many, many microsatellites and whether they have this DNA instability in the microsatellites. Dr. Rafeh Naqash: Excellent explanation. As a segue to what you just mentioned, and this reminds me of some work that one of my good friends, collaborators, Amin Nassar, whom you also know, I believe, had done a year and a half back, was published in Cancer Cell as a brief report, I believe, where the concept was that when you look at these mismatch repair deficient cancers, there is a difference between NGS testing, IHC testing, and maybe to some extent, PCR testing, where you can have discordances. Have you seen that in your clinical experience? What are some of your thoughts there? And if a trainee were to ask, what would be the gold standard to test individuals where you suspect mismatch repair deficient-related Lynch syndrome cancers? How would you test those individuals? Dr. Asaf Maoz: We do sometimes see discordance, you know, from large series, the concordance rate is very high, and in most series it's over 95%. And so from a practical perspective, if we're thinking about the recommendation to screen all colorectal cancer and all endometrial cancer for mismatch repair deficiency, I think either PCR-based testing or immunohistochemistry is acceptable because the concordance rate is very high. There are rare cases where it is not concordant, doing multiple of the tests makes sense at that time. If you think about the difference between the tests, the immunohistochemistry looks at protein expression, which is a surrogate for whether there is mismatch repair deficiency or not, right? Because ultimately, the mismatch repair deficiency is manifested in the mutations. So if the PCR does not show microsatellite instability and now NGS does not show microsatellite instability, the IHC may be a false positive. At the end of the day, the functional analysis of whether there are actually unstable microsatellites either by PCR or by NGS is what I would consider more informative. But IHC again is an excellent test and concordant with those results in over 95% of cases. Now there is also an issue of sampling. It's possible that there's heterogeneity within the tumor. We published a case in JCOPO about heterogeneity of the mismatch repair status, and that was both by immunohistochemistry, but also by PCR. So there are some caveats and interpreting these tests does require some expertise, and I'm always happy to chat with trainees or whoever has an interesting or challenging case. Dr. Rafeh Naqash: Thanks again for that very easy to understand explanation. Now going to management strategies, could you elaborate a little bit upon the neo-adjuvant data currently, or the metastatic data which I think more people are familiar with for immunotherapy in individuals with MSI-high cancers? Dr. Asaf Maoz: Yeah, that's an excellent question and obviously a very broad topic. Individuals with Lynch syndrome typically develop tumors that are mismatch repair deficient or microsatellite unstable. And we have seen over the last 15 years or so that these tumors, because they have a lot of mutations and because these mutations are very immunogenic, we have seen that they respond very well to immunotherapy. And this has been shown across disease sites and has been shown across disease settings. And for that reason, immunotherapy was approved for MSI-high or mismatch repair deficient cancer regardless of the anatomic site. It was the first tissue-agnostic approval by the FDA in 2017. And so there are exciting studies both in the metastatic setting where we see individuals who respond to immunotherapy for many years, and one could wonder whether their cancer is going to come back or not. And also in the earlier setting, for example, the Cercek et al. study in the New England Journal from Sloan Kettering, where they showed that neoadjuvant immunotherapy can cause durable responses for rectal cancer that is mismatch repair deficient. And in that series, the patients did not require surgery or radiation, which is standard of care for rectal cancer otherwise. And there's also exciting data in the adjuvant space, as was presented in ASCO by Dr. Sinicrope, the ATOMIC study, and many more efforts to bring immunotherapy into the treatment landscape for individuals with MSI-high cancer, including individuals with Lynch syndrome. Dr. Rafeh Naqash: A lot of activity, especially in the neo-adjuvant and adjuvant space over the last two years or so. Now going to the actual reason why we are here is your study. Could you tell us why you looked at this idea of patients who had Lynch syndrome and died, and the reasons for their death? What was the thought that triggered this project? Dr. Asaf Maoz: As we were talking about, we now know that immunotherapy really has changed the treatment landscape for individuals with Lynch syndrome, and that most cancers that individuals with Lynch syndrome do have this mismatch repair deficiency. But we also know that individuals with Lynch syndrome can develop tumors that do not have mismatch repair deficiency, and we call them mismatch repair proficient or microsatellite stable. And there was a series from Memorial Sloan Kettering showing that in colorectal cancer, about 10% of the tumors that individuals with Lynch syndrome developed did not have mismatch repair deficiency. In addition to that, we anecdotally saw that some of our patients with Lynch syndrome died of causes that were not mismatch repair deficient tumors. We wanted to see how that has changed since immunotherapy was approved in a tissue-agnostic manner, meaning that we could look at this regardless of where the cancer started, because we would anticipate that if the tumor was mismatch repair deficient, the patient would be able to access immunotherapy as standard of care. Dr. Rafeh Naqash: Thank you. And then you looked at different aspects of correlations with regards to individuals that had an MSI-high cancer with Lynch syndrome or an MSS cancer with Lynch syndrome. Could you elaborate on some of the important findings that you identified as well as some of the unusual findings that perhaps we did not know about, even though the sample size is limited, but what were some of the unique things that you did identify through this project? Dr. Asaf Maoz: The first question was what cause is leading to death in individuals with Lynch syndrome? And we had 54 patients that we identified that had died since the approval of immunotherapy in 2017, 44 of which died of cancer-related causes. And when we looked at cancer-related causes of death, we wanted to know how many of those were due to mismatch repair deficient tumors versus mismatch repair proficient tumors or MS-stable tumors. And we found, somewhat surprisingly, that 43% of patients in our cohort actually died of tumors that were microsatellite stable or mismatch repair proficient, meaning of tumors that are not typically associated with Lynch syndrome. This is not entirely surprising as a cause of death because we know that immunotherapy does not typically work for tumors that are microsatellite stable. And so in the metastatic setting, there are much less cases of durable remissions with treatment. But it was helpful to have that figure as an important benchmark. There are previous studies about causes of death in Lynch syndrome, and particularly from the Prospective Lynch Syndrome Database in Europe. Those have provided really important information about cause of death by cancer site, but they typically don't have mismatch repair status and are more difficult to interpret in that regard. They also don't include a large number of individuals who have PMS2 Lynch syndrome, which is the most common, but least penetrant form of Lynch syndrome. Dr. Rafeh Naqash: As far as the subtype of pathogenic germline variants is concerned, did you notice anything unusual? And I've always had this question, and you may know more about this data, is: In the bigger context of immunotherapy, does the type of the pathogenic germline variant for Lynch syndrome associated MSI-high cancers, does that impact or have an association with the kind of outcomes, how soon a cancer progresses or how many exceptional responders perhaps with MSI-high cancers actually have a certain specific pathogenic germline variant? Dr. Asaf Maoz: That's an excellent question, and certainly we need more data in that space. We know that the type of germline mutation, or the gene in which there is a germline pathogenic variant, determines to a large degree the cancer risk, right? So we know that individuals who have germline pathogenic variants in MLH1 or MSH2 have a much higher colorectal cancer risk than, for example, PMS2. We know that for PMS2, the risks are more limited to colorectal and endometrial, and may be lower risk of other cancers. We also know that, you know, the spectrum of disease may change based on the pathogenic germline variants. For example, individuals who have MSH2 associated Lynch syndrome have more risk of additional cancers in other organs like the urinary tract and other less common Lynch-associated tumors. The question about response to therapy is one where we have much less information. There are studies that are trying to assess this, but I don't think the answer is there yet. Some of the non-clinical data looks at how many mutations there are based on the pathogenic variant and what the nature of those mutations are, whether they're more frameshift or others. But I think we still need more clinical data to understand whether the response to immunotherapy differs. It's also complicated by the fact that the immunotherapy landscape is changing, especially in the metastatic setting, now with the approval of combination ipilimumab and nivolumab for first-line treatment of colorectal cancer that is microsatellite unstable. But in our study, we did find that, as you would expect, there is an enrichment in MS-stable cancers among those with PMS2 Lynch syndrome. Again, our denominator is those who died, right? So this is not the best way to look at the question whether this is overall true, that is more addressed by the study that Sloan Kettering published. But we do see, as we would anticipate, that there are more microsatellite stable cancers among those with PMS2 Lynch syndrome that died. Dr. Rafeh Naqash: A lot to uncover there for sure. This study and perhaps some of the other work that you're doing is slowly advancing our understanding of some of these concepts. So I'd like to shift gears to a couple of provocative questions that I generally like to ask. The first is, in your opinion, and you may or may not have data to back this up, which is okay, and that's why we're having a conversation about it. In your opinion, do you think the type or the quality of the neoantigen is different based on the pathogenic germline variant and a Lynch syndrome associated MSI-high cancer? Dr. Asaf Maoz: I think there are some data out there that, you know, I can't cite off the top of my mind, but there are some data out there that suggest that that may be the case. I think the key question is the quality, right? I think that whether these differences that are found on a molecular level also translate to a clinical difference in response is something that is unknown at this moment. Some people hypothesize that if the tumor has less neoantigens, there's less of a response to immunotherapy. But I think we really need to be careful before making those assertions on a clinical level. I do think it's a really important question that needs to be answered, among others because, you know, in the colorectal space, for example, where we have both the option of doing ipilimumab with nivolumab and the option of doing pembrolizumab, we don't really know which patients need the CTLA-4 blockade versus which patients can receive PD-1 blockade alone and avoid the potential excess toxicity of the CTLA-4 blockade. There are a lot of interesting questions there that still need to be answered. And of course, individuals with Lynch syndrome are just a fraction of those individuals who have MSI-high cancer. So there's also the question about whether non-Lynch syndrome associated MSI-high cancer responds differently to immunotherapy than Lynch syndrome associated MSI-high cancer. A lot of very interesting questions in the field for sure. Dr. Rafeh Naqash: Absolutely. My second question is more about trying to understand the role of ctDNA, MRD monitoring in individuals with Lynch syndrome. If somebody has a germline, you know, Lynch syndrome MSI-high cancer, when you do a tumor-informed ctDNA assessment, what do you capture generally there? Because, and this question stems from a discussion I've had with somebody regarding EGFR lung cancer, since I treat individuals with lung cancer, and the concept generally is that even if the tissue showed EGFR, but for MRD monitoring, when you do a barcoded sequence of different tumor specific mutations, it's not actually the EGFR that they track in the blood when they do ctDNA assessment. But from a Lynch syndrome standpoint, if you have a germline, right, which is the first hit, and then you have the somatic in the tumor, which is the second hit, are you aware or have you tried to look into this where what is exactly being followed if one had to follow MRD in a Lynch syndrome MSI-high colorectal cancer? Dr. Asaf Maoz: I think a lot of the MRD assays are proprietary, and so we don't receive information about what the mutations that are being tracked are. In general, the idea is to track mutations that we would not expect to disappear as part of resistant mechanisms. We want these to be truncal mutations. We want these to be mutations in which resistance is not expected to result in reversion mutations. But what specifically is being tracked is something that I don't know because these assays, the tumor-informed ones, are proprietary, and we don't get the results regarding specific mutations. When it's circulating tumor DNA that is not necessarily tumor-informed, we do get those results, but that is less so about the specific selection of mutations. Dr. Rafeh Naqash: Thank you for clarifying that question to some extent, of course, as you said, we don't know a lot, and we don't know what we don't know. That's the most important thing that I've learned in the process of understanding precision medicine and genomics, and it's a very fast-paced evolving field. Last question related to your project, what is the next step? Are you planning any next steps as a bigger multicenter study or validation of some sort? Dr. Asaf Maoz: There are two big questions that this study raises. One, is this true across multiple other sites, right? Because this is a single center study, and we really need additional centers to look at their data and validate whether they are also seeing that a substantial portion of deaths in individuals with Lynch syndrome are attributable to mismatch repair proficient cancer. The other question is whether we can look at specifically MSI-high cancer versus MS-stable cancer and understand what the mortality rate for each of those are. From a clinical perspective, it's important to counsel individuals with Lynch syndrome about general cancer screening outside of mismatch repair deficient tumors and to understand that there is also a risk of mismatch repair proficient tumors and that treatment for those tumors would be different. There's a lot of work to be done in the future. Another major area of need is to see whether tumors that are microsatellite stable can be sensitized to immunotherapy, and that is beyond the Lynch syndrome field, but that is something that certainly would benefit these individuals with Lynch syndrome who develop mismatch repair proficient cancer. Dr. Rafeh Naqash: That's very interesting to hear, and we'll look forward to seeing some of those developments shape in the next few years. Now, I'd like to spend a minute, minute and a half on you specifically as a researcher, clinician, scientist. Could you briefly highlight - because I remember meeting you several years back as a trainee, with your interest in genomics, computational research - could you briefly tell us what led you to hereditary cancer syndromes based on your research and work? What are some of the things that you learned along the way that other early career investigators can perhaps take lessons from? Dr. Asaf Maoz: Big questions there, thanks for asking. I got interested in the field of hereditary cancer syndromes when I came to the United States and started doing lab research in Stephen Gruber's lab at the time at USC. He's now at City of Hope. And my interest was originally looking at immunotherapy and immunology, but I went to the case conferences where we were learning about individuals with hereditary cancer, and those were kind of earlier days where we were still trying to figure out how to test and what the implications for these individuals would be. And through fellowship, I was also very interested in that, and I did my senior fellowship years with Dr. Yurgelun here at Dana-Farber, who is the director of the Lynch Syndrome Center. And I I think it's the combination between being able to treat individuals based on precision medicine and what the germline mutation is, but also the ability to prevent cancer and to develop strategies to intercept cancer early that is really appealing to me in this field. It's also a great field to be in because it's a small field. If you come to the CGA-IGC meeting, you'll be able to interact with everyone. Everyone is super collaborative, super nice, and I really recommend it to trainees. The CGA-IGC annual meeting is really a great opportunity to learn more and experience some of the advancement specifically in the GI hereditary space. Lessons for trainees. I think there are a lot of lessons that I could think about, but I think finding strong and supportive mentors is one of the things that has helped me most. I think that just having close relationship with your mentor, having frequent discussions and honest discussions about what is feasible, what is going to make a difference for your patients and your research and what you want to focus on is really important. And so I think if I had to choose one thing, I would say choose a mentor that you trust, that you feel you have a good relationship with, and that has the availability to support you. Dr. Rafeh Naqash: Thank you so much for those insightful comments, and thank you for sharing with us your journey, your project, and some of your interesting thoughts on this concept of hereditary cancers. Hopefully, we'll see more of this work being published in JCOPO through your lab or work from others. Dr. Asaf Maoz: Thank you so much. I appreciate the opportunity to be here. Dr. Rafeh Naqash: Thank you for listening to JCO Precision Oncology Conversations. Don't forget to give us a rating or review and be sure to subscribe so you never miss an episode. You can find all ASCO shows at ASCO.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

This is a free preview of a paid episode. To hear more, visit zeteo.comIt has been two years since October 7th, 2023 – when Hamas launched the deadliest attack in Israel's history. Around 1,200 people were brutally killed – including over 700 civilians and dozens of children. 251 people were taken hostage into Gaza, and over 80 are now confirmed dead, including those killed on Oct. 7.Since then, Israel has used that terrifying day to justify even worse atrocities in Gaza, killing over 67,000 Palestinians, 83% of whom were civilians. It is the first-ever live-streamed genocide, with images and videos of starving Palestinian children, a demolished Gaza, and gleeful Israeli military soldiers being shared across our social feeds every single day.But even though it's clear that Israel has caused far more death and destruction than even Hamas did on Oct. 7, it doesn't mean Oct. 7 was anything other than a tragedy for the innocent Israeli civilians who were either murdered or taken hostage two years ago today.In fact, some of the Israelis who suffered the most heart-wrenching losses from Hamas's attack on Oct. 7 have now actually become some of the biggest advocates for peace and most fervent critics of the Netanyahu government.In this ‘Mehdi Unfiltered' interview, I speak to two of those people: Zahiro Shahar Mor, whose uncle Avraham Munder was taken hostage on Oct. 7. His uncle's body was recovered last year in Khan Younis. Throughout the war, Zahiro has been arrested multiple times for protesting against the government's handling of the war and advocating for a hostage deal – and even been beaten by Israeli police.Then there is Israeli peace activist Maoz Inon, whose parents Bilha and Yakov Inon were both killed two years ago today, during the Oct. 7 attack. Since then, Maoz has dedicated himself to forgiveness and reconciliation, and has built partnerships with Palestinians to try and envision a future beyond war and revenge.I think you'll find my conversation with these two men to be powerful, heartbreaking, and full of wisdom. Zahiro acknowledges that much of Israeli society has been taken over by genocidal fever since Oct. 7, saying that, “concerning Israeli society's attitude toward Gaza…it's like a black hole over there.”Meanwhile, Maoz's steadfast belief in radical forgiveness, despite all he's been through since the killing of his parents on Oct. 7, is truly stunning and awe-inspiring.“The most important lesson I learned after October 7th is the power of forgiveness… I forgive Hamas for murdering my parents. And I forgive Benjamin Netanyahu and his government for sacrificing them,” Maoz says to me.Please do take the time to watch this unique conversation and hear why the two of them still hold onto hope, despite Netanyahu's constant sabotaging of ceasefire negotiations and hostage deals.Paid subscribers can watch the interview in full, without a paywall. Free subscribers can watch a 5-minute preview of the interview above. Do consider upgrading to a paid subscription to unlock the full interview and support our independent journalism.Editor's Note: This conversation was recorded before Hamas officially entered negotiations with Israel on Trump's peace plan for Gaza last week.Do also check out Mehdi's recent interview with Palestinian journalist Ahmed Alnaouq and social-justice activist Pam Bailey on their new and moving book on Gaza, ‘We Are Not Numbers':

What happens when we give machines the power to think without ensuring they share our values? This riveting conversation dives deep into one of humanity's most pressing challenges: controlling artificial intelligence as it grows increasingly powerful.Joined by Roni Abovitz, founder of groundbreaking companies Mako Surgical and Magic Leap, and neuroscientist Dr. Uri Maoz from Chapman University, we explore the profound question of AI intentions. Abovitz introduces a compelling biological metaphor, suggesting we view AI systems not as a monolith but as different "species"—some benign like golden retrievers, others potentially dangerous as velociraptors. This framing helps us understand that the path forward isn't about controlling "AI" but about deliberately creating systems with built-in safeguards and beneficial intentions.The conversation takes a sobering turn as Dr. Maoz highlights the vast speed differential between human thought and machine processing. "A second to us is two weeks to them," he explains, illustrating why prevention and foresight are essential—by the time we recognize a problem, an advanced AI could have spent the equivalent of months planning countermeasures.We examine how the global "AI overmatch" race parallels historical arms races, with nations pushing development forward at breakneck speed without adequate safety considerations. Unlike nuclear weapons, which created a mutually-assured destruction dynamic discouraging their use, AI lacks clear restraint mechanisms—and the technology can spread globally within hours once developed.Despite these challenges, our guests offer hope through emerging efforts to build intentionally benign systems. Abovitz notes that while many developers chase power above all, there exists a "Jedi Rebel Alliance" of technologists committed to creating safe, beneficial AI. His conversations with Fortune 500 CEOs reveal that business leaders overwhelmingly want AI that helps their companies without harming employees or humanity—suggesting potential market pressure for safer development paths.Listen as we navigate this critical moment in human history and explore what's needed to ensure AI enhances rather than endangers our collective future. The time to shape these technologies with wisdom and foresight is now—before the T-Rex breaks through the fence.Support Our WorkThe Center for Demographics and Policy focuses on research and analysis of global, national, and regional demographic trends and explores policies that might produce favorable demographic results over time. It involves Chapman students in demographic research under the supervision of the Center's senior staff.Students work with the Center's director and engage in research that will serve them well as they look to develop their careers in business, the social sciences, and the arts. Students also have access to our advisory board, which includes distinguished Chapman faculty and major demographic scholars from across the country and the world.For additional information, please contact Mahnaz Asghari, Associate Director for the Center for Demographics and Policy, at (714) 744-7635 or asghari@chapman.edu.Follow us on LinkedIn:https://www.linkedin.com/company/the-feudal-future-podcast/Tweet thoughts: @joelkotkin, @mtoplansky, #FeudalFuture #BeyondFeudalismLearn more about Joel's book 'The Coming of Neo-Feudalism': https://amzn.to/3a1VV87Sign Up For News & Alerts: http://joelkotkin.com/#subscribeThis show is presented by the Chapman Center for Demographics and Policy, which focuses on research and analysis of global, national and regional demographic trends and explores policies that might produce favorable demographic results over time.

find more at http://www.RickBurgessShow.comSee omnystudio.com/listener for privacy information.

Since 2023, Aziz and Moaz have joined forces in their pursuit for peace, traveling globally and sharing their message of peace and hope with all who will listen. Together, they co-lead InterAct International, a non profit advancing sustainability, education, and cross cultural connections. Aziz and Maoz carry the weight of personal tragedies inflicted by the Israeli-Palestinian conflict but they are transforming their pain into a shared pursuit of peace for all. Hosted by Rabbi Chaim Koritzinsky of Congregation Etz Chayim, and Pastor Danielle Parish of Spark Church, both located in Palo Alto, CA

Since 2023, Aziz and Moaz have joined forces in their pursuit for peace, traveling globally and sharing their message of peace and hope with all who will listen. Together, they co-lead InterAct International, a non profit advancing sustainability, education, and cross cultural connections. Aziz and Maoz carry the weight of personal tragedies inflicted by the Israeli-Palestinian conflict but they are transforming their pain into a shared pursuit of peace for all. Hosted by Rabbi Chaim Koritzinsky of Congregation Etz Chayim, and Pastor Danielle Parish of Spark Church, both located in Palo Alto, CA

Maoz Inon - Building Lasting Peace Post 07/10In this transformative conversation on ROPESCAST, we welcome Israeli entrepreneur and peace activist Maoz Inon, whose personal journey exemplifies extraordinary resilience and vision in the face of tragedy.On October 7, 2023, Maoz lost both of his parents in the Hamas terror attack, yet he has found the courage and forgiveness in his heart to continue advocating for peace between Israelis and Palestinians. His story is one of transforming personal grief into a catalyst for positive change and reconciliation.Maoz shares his profound insights on peace-building, forgiveness, and how to create meaningful change even in the darkest times:"Forgiveness is the key to redeem ourselves, to free ourselves from the destiny those who harmed us chose for us. They choose for us to hate each other, but many of us are choosing a different destiny based on reconciliation and healing and human values."Perhaps most moving is his perspective on hope: "Hope is not something we can find and is not something we can lose - hope is an action. And the formula to create hope is also very simple. It's difficult to achieve but it's very simple to explain. We create hope by working together with others and envisioning a better future and acting to make it into a reality."Join us for this deeply moving conversation that transcends politics and reminds us of our shared humanity and the power of choosing reconciliation over revenge.ROPESCAST is produced by the Regional Organization for Peace, Economics & Security (ROPES), bringing together voices from across the Middle East to foster dialogue, understanding, and cooperation.

On March 3rd, we welcomed Maoz Inon and Aziz Abu Sarah, Israeli and Palestinian leaders at the forefront of a burgeoning new peace movement in conversation with Rabbi Sharon Brous.

J.J. and Dr. Maoz Kahana are at Altona-Hamburg-Wandsbek's biggest fight night. This Rabbinic brawl over Sabbateanism in the 18th century bruised Jewish leaders all over Europe. Follow us on Bluesky @jewishideaspod.bsky.social for updates about messiahs, true and false. Please rate and review the the show in the podcast app of your choice!We welcome all complaints and compliments at podcasts@torahinmotion.org  For more information visit torahinmotion.org/podcastsMaoz Kahana (PhD) is an associate Professor  in the Jewish History Department, Tel Aviv University. His research focuses on deciphering and elucidating rabbinical literature and Jewish law and legal cultures within the social and intellectual contexts of the early modern and modern European history as well as its minority Jewish culture.  His research and teaching integrates intellectual and social history; legal and cultural methods. Characteristic themes of his work are print and book history, the scientific revolution, magic, law, and the divine; Rabbi's allure to Sabbatian literature, Chassidic Halakhic writings, Jewish legal cultures and European romanticism,  the emergence of European coffeehouses, and others. His book: Halakhic Writing in a Changing World, from the ‘Noda B'yhuda' to the ‘Hatam Sofer', 1730-1839, based on his doctoral :dissertation, was published in the Zalman Shazar Publication House, Jerusalem (2015). A second book: “A Heartless Chicken and other Wonders: Religion and Science in Early Modern Rabbinic Culture”, was published (2021) in Bialik Institute Publishing House, Jerusalem. His newest 

WOW!!!

LISTEN!!!

This morning we discuss the famous Chanukah song, Maoz Tzur. We explore the importance of singing it while we contemplate the Chanukah lights. And we examine its themes and lessons, especially as they relate to us this year, 5785/2024. We also include a wonderful story from Rabbi Meilech Biderman about lighting Chanukah candles on a hectic Friday afternoon. Michael Whitman is the senior rabbi of ADATH Congregation in Hampstead, Quebec, and an adjunct professor at McGill University Faculty of Law. ADATH is a modern orthodox synagogue community in suburban Montreal, providing Judaism for the next generation. We take great pleasure in welcoming everyone with a warm smile, while sharing inspiration through prayer, study, and friendship. Rabbi Whitman shares his thoughts and inspirations through online lectures and shiurim, which are available on: YouTube: / @rabbimichaelwhitman Instagram: / adathmichael Podcast - Mining the Riches of the Parsha: Apple Podcasts: https://podcasts.apple.com/ca/podcast... Spotify: https://open.spotify.com/show/3hWYhCG... Please contact Rabbi Whitman (rabbi@adath.ca) with any questions or feedback, or to receive a daily email, "Study with Rabbi Whitman Today," with current and past insights for that day, video, and audio, all in one short email sent directly to your inbox.

HANUKA

Send us a textAziz Abu Sarah and Maoz Inon are tourism entrepreneurs and peace activists that have been working for peace in Palestine and Israel for years. Hamas militants killed Maoz's parents on October 7th and Israeli prison guards beat Aziz's brother so severely that he died after being released from prison. Recently, they joined forces and are now traveling across the United States speaking about the need for Americans to act now for peace in the Middle East because inaction itself is a risk. They argue that their relationship, built on the basis of equality, offers a path toward reconciliation. The path of violence has led nowhere and the US has forgotten the art of diplomacy in its foreign policy.

durée : 00:04:23 - Comme personne - par : Jeanne Cerin - À quelques jours du triste anniversaire du 7 octobre, le Comme personne s'intéresse à deux hommes, Maoz Inon et Aziz Abu Sarah. Un israélien et un palestinien, amis et devenus, depuis un an, des ambassadeurs pour la paix.

Maoz Inon & Aziz Abu Sarah, a Palestinian and a Jew, visited our Politics Done Right set at Netroots Nation 2024 to discuss their work to create peace between Palestinians and Jews, especially given the crisis in Gaza. Subscribe to our Newsletter: https://politicsdoneright.com/newsletter Purchase our Books: As I See It: https://amzn.to/3XpvW5o How To Make America Utopia: https://amzn.to/3VKVFnG It's Worth It: https://amzn.to/3VFByXP Lose Weight And Be Fit Now: https://amzn.to/3xiQK3K Tribulations of an Afro-Latino Caribbean man: https://amzn.to/4c09rbE

Join Maoz Inon, award winning Israeli peace activist and social entrepreneur, as he transforms personal tragedy into a powerful mission for peace and coexistence. After losing his parents in the October 7th tragedy, Maoz's commitment to bridging divides between Israelis and Palestinians only grew stronger. Discover how conscious tourism fosters cross cultural understanding and economic support to strengthen both Arab neighborhoods and Jewish-Arab solidarity in Israel. Maoz shares intimate reflections on his upbringing with peace activist parents, the profound impact of empathy over revenge, and the vital role of international support and grassroots organizations in amplifying the voices of peace-builders. This episode delves into themes of forgiveness, resilience, social impact and the power of human connection.⭐ Please consider leaving us a review on apple podcasts to help us grow.

Paul Liberman became a believer in the Messiah in 1971. He was instrumental in founding two Messianic Congregations; Beth Messiah Messianic Congregation in Washington, D.C. and Tree of Life in San Diego, California.  He also served as a congregational leader at Beit Asaph in Netanya, Israel, when he resided in the Land for nine years.  There, he was the Executive Director of The Joseph Project, Ltd. (humanitarian aid importer), and was elected Chairman of the Messianic Political Action Committee.  For five years, he served as the Executive Director of the International Messianic Alliance.  Paul was also the publisher of “The Messianic Times” newspaper for six years, a founding board member of MAOZ, Inc. (Israel) and is a past President of the Messianic Jewish Alliance of America.  Currently he is the leader of Ohav Shalom Messianic Congregation in Palm Springs, California. He is the author of “The Fig Tree Blossoms” and “Don't Call Me Christian.”

Aziz Abu Sarah is a peace builder, cultural educator, entrepreneur, author and international speaker. He's also a Palestinian man who lost his brother to the Israeli soldiers and who is currently working with his Israeli partner, Maoz Inon, to imagine a new vision for both Palestinians and Israelis. If there is only one episode you will tune in to this season, let it be this one, because it will give you an idea of how to talk to people who don't have the same values as you when it comes to Palestine - Israel, one of the most important issues and injustices of our time.Aziz is a National Geographic Explorer and a TED Fellow who co-founded Mejdi Tours, a travel company that takes people to places like Palestine/Israel, Northern Ireland, and South Africa and presents multiple narratives about those places. His recent efforts with Maoz Inon include a Ted talk titled A Palestinian And Israeli, Face To Face, and meeting Pope Francis in time for the G7 Summit. What you'll learn in this episode:What it's like to meet with Pope FrancisHow Aziz stays engaged in the face of pain and lossA Palestinian and an Israeli joining forcesAziz tells the story of losing his brother and becoming a peacemakerWhat it's like living under the Israeli apartheid structureWhat Aziz wants people to see when they see PalestiniansThe power of poetry in Palestinian cultureMejdi Tours and the Dual Narrative methodSeeing beyond tourism stereotypes in EgyptThe asymmetry between Palestine and IsraelThe crux of Aziz's peacemaking approachMoving beyond pro-Palestinian and pro-Israeli labelsFighting fear with hopeWhat the peacemaking vision in Palestine and Israel looks likeHow you can get involved in the peacemaking processWhy Aziz thinks hope is an actionFeatured on the show:Learn more about Aziz on his website Read Aziz's Ted Ideas story, How I Learned to Forgive My Brother's MurderersCheck out the Ted Talk by Aziz and Maoz, A Palestinian And An Israeli, Face To FaceRead Al Jazeera op-ed by Aziz and Maoz, When It Comes to Israel-Palestine, True Naivety Is Believing in Endless WarLearn more about Mejdi ToursLearn more about Land For AllGet involved at InterActLearn more about the Palestinian poet Samih al-QasimFollow Aziz Abu Sarah on InstagramFollow Maoz Inon on InstagramCheck out Aziz's book, Crossing Boundaries: A Traveler's Guide to World PeaceGet more information at: Going...

Recording of our June 20, 2024 webinar with Aziz Abu Sarah and Maoz Inon. This conversation was hosted by Hadar Susskind and Maxxe Albert-Deitch. Aziz Abu Sarah and Maoz Inon feel the loss and pain of October 7th and the carnage in Gaza that has followed especially keenly: both have lost family to the conflict. Since October 7th, the two have appeared on various international forums regarding their partnership in establishing peace between Israelis and Palestinians. Most recently, they traveled together to Verona, Italy to meet Pope Francis and share their vision for the future: one where Israelis and Palestinians can move forward and live side by side.  Aziz Abu Sarah is a Palestinian peacebuilder, entrepreneur, and international speaker. He is the co-founder of InterAct International and MEJDI Tours, and the former executive director of the Center for World Religions, Diplomacy and Conflict Resolution at George Mason University. Maoz Inon is an Israeli social entrepreneur and peace activist. He has founded several tourism initiatives in Israel and in the Middle East, including the Fauzi Azar Inn and Abraham Hostel and Tour brands.  

In this episode, Amira and Ibrahim are joined by their dear friend Maoz Inon. Maoz is an award winning Israeli social entrepreneur and peace activist who has founded several tourism initiatives with Israel & the Middle East. Maoz's life changed drastically when his parents were one of the first identified victims of the Oct 7th massacre. Tune in to know more about his heartbreaking story and the lessons he has learned.

How can Israel and Palestine achieve peace? Palestinian peacemaker Aziz Abu Sarah and Israeli peacemaker Maoz Inon discuss the immeasurable tragedies they've experienced growing up in the region — and how they choose reconciliation over revenge, again and again. With a fierce belief in a better future, they talk about conflict, safety, finding shared values and how they're building a coalition of Israeli and Palestinian citizens who are intent on creating a path to hope and peace.

How can Israel and Palestine achieve peace? Palestinian peacemaker Aziz Abu Sarah and Israeli peacemaker Maoz Inon discuss the immeasurable tragedies they've experienced growing up in the region — and how they choose reconciliation over revenge, again and again. With a fierce belief in a better future, they talk about conflict, safety, finding shared values and how they're building a coalition of Israeli and Palestinian citizens who are intent on creating a path to hope and peace.

How can Israel and Palestine achieve peace? Palestinian peacemaker Aziz Abu Sarah and Israeli peacemaker Maoz Inon discuss the immeasurable tragedies they've experienced growing up in the region — and how they choose reconciliation over revenge, again and again. With a fierce belief in a better future, they talk about conflict, safety, finding shared values and how they're building a coalition of Israeli and Palestinian citizens who are intent on creating a path to hope and peace.

In this episode, I interviewed Maayan, Maoz's sister, who gave us an incredibly powerful interview a few weeks ago about letting go of revenge. With Maayan, we will be discussing death, as her parents were one of the first to lose their lives in the Israel/Palestine conflict.  We talk about: Her powerful drowning story  What is death? The relationship between life and death How can we deal better with death and connect to people who have passed How she has been dealing with her parents' passing  About Maayan: Born in 1973, and raised in Kibbutz Nir-Am near the Gaza Strip. On 7/10, Maayan lost her parents who were burned in their home in Moshav Netiv Haasara. Mother of 2 daughters and a dog, Physiotherapist, practiced Chinese medicine, reflexology, healing, and family constellations. For up to 30 years, she has researched and engaged in consciousness work, and practices listening and creating healthy relationships within herself and with the environment. In her work she specialized in accompanying transitions - birth, life and death. She has developed programs for training mind-body therapists, and deals with trauma and post-trauma healing, dealing with bereavement and loss. ❥❥❥ ✨Connect with Maayan http://maayan-inon.com/ ❥❥❥ Apply for 1-1 coaching with me: https://forms.gle/ecM2ehvDveR2KMqv7 Thank you so much for being here! I appreciate and love you so much. Please take a moment to rate the show and subscribe - it would mean the world to me! ALL of my online courses can be found here: https://marinayt.com/courses/  These courses support you in using the deepest layer of transformation - your body - to get to the root cause of why you may feel stuck or triggered, and make profound shifts in your relationships and your work. I love these courses so much because they go so deep - to the root, rather than just giving you surface level communication or action tips. Nearly 1,000 students

Staff Sgt. Maoz Morell, 22, a member of the Paratroopers Brigade who was injured February 15 during fighting in the southern Gaza Strip, succumbed to his wounds on February 19.

In this powerful episode, I speak with Maoz Inon, who lost his parents and so many people in the first days of the conflict between Israel and Palestine. We speak deeply in this podcast about Maoz's very real and emotional journey, how he found forgiveness and peace over revenge, and how we can all work together to create a more peaceful society.  This is truly one of the most profound and touching conversations I have had on this podcast, and probably ever. Maoz is not just about words - the actions he takes and the man he embodies is undeniably powerful, and I am so excited to hear how you feel in your body after witnessing this conversation.  ❥❥❥ HeartSpace is a space to learn how to live with an open heart. Those of us with huge hearts need profound tools of navigating our nervous system and emotions in order to keep up the ability to open our hearts. I am going to teach you this AND MORE, plus beautiful connections with fellow lion hearts! HeartSpace is only $33/month. Join here: ⁠www.marinayt.com/HeartSpace⁠  ❥❥❥ Thank you so much for being here! I appreciate and love you so much. Please take a moment to rate the show and subscribe - it would mean the world to me! ALL of my online courses can be found here: https://marinayt.com/courses/  These courses support you in using the deepest layer of transformation - your body - to get to the root cause of why you may feel stuck or triggered, and make profound shifts in your relationships and your work. I love these courses so much because they go so deep - to the root, rather than just giving you surface level communication or action tips. Nearly 1,000 students

Click here for the full interviews with Asa Winstanley and Maoz Inon: https://www.usefulidiotspodcast.com/p/extended-episode-son-of-israeli-victims?r=je5va&utm_campaign=post&utm_medium=web For $6 a month, become a Useful Idiot! Get extended interviews, Thursday Throwdowns, and bonus content at www.usefulidiotspodcast.com Watch this week's Thursday Throwdown: Adam Schiff mourns the genocide he's supporting https://www.usefulidiotspodcast.com/p/adam-schiff-mourns-the-genocide-hes?r=je5va&utm_campaign=post&utm_medium=web “I see the government of Israel as accountable for October 7th.” Israeli peace activist Maoz Inon lost both of his parents on October 7th. And while many Israelis who didn't lose anyone want increased bloodshed, Maoz's calls for peace show compassion and bravery. “It's very difficult in Israeli society to speak out right now, and he's one of the few people doing it. He's not letting his tragedy become weaponized to create even more tragedies.” While it's still unclear which side ultimately killed his parents, Maoz says it doesn't matter: “Maybe you're right, maybe they were killed in Israeli crossfire. But what does it matter? What does it matter? My parents died because of the Palestinian-Israeli conflict. And I decided to commit my life to making peace. What does it matter who killed them. They were killed because of the conflict, and I'm going to make peace from the river to the sea.” And though Israeli police make it dangerous, Maoz is protesting in Israel “with a very direct call and message that the government is accountable and the government must go.” As information comes out about the events of October 7th, Israel's role in the death count of its own civilians continues to increase. So we also interviewed Asa Winstanley, a journalist with the Electronic Intifada, whose reporting shows more and more evidence that Israeli forces killed their own people on October 7th. He explains that even today, with Israeli hostages still in Gaza, the Israeli government shows no signs of letting up their deadly assault. “It's starting to seem like the political leaders of Israel do not want those captives to come home alive.” Subscribe for the full interview with Asa Winstanley where he uncovers more Israeli military fabrications and we discuss an article in the Washington Post that smeared Asa, the Electronic Intifada, and the Grayzone. 00:00 Intro 4:34 The Four Food Groups of News 17:51 Asa Winstanley interview 19:42 What really happened on October 7th? 28:18 The Hannibal Directive 39:00 Israel or Hamas? 46:51 Maoz Inon interview 47:36 What happened to Maoz's parents 53:58 How Israel has responded to October 7 57:08 Could Israel have prevented it? 1:04:56 Who is responsible? 1:17:17 A call for peace Learn more about your ad choices. Visit podcastchoices.com/adchoices

LISTEN!!!

LISTEN!!!

Everything in this corner of the world has changed since Saturday, October 7. All around us, friends, family, colleagues, people have died. People are missing. People have been kidnapped. There's a lot of uncertainty and we're all involved in dozens of initiatives but we're also going to bring you some voices and testimonies that try to paint a picture of these devastating times.The end song is Imperiot Noflot Le'at ("Empires Fall Slowly") by Dan Toren and Hemi Rudner. Hosted on Acast. See acast.com/privacy for more information.